|
|
|
篇目详细内容 |
|
【篇名】 |
Relationship of endothelial nitric oxide synthase gene polymorphism with blood pressure, lipid profile and blood glucose level |
|
【刊名】 |
Frontiers of Medicine in China |
|
【刊名缩写】 |
Front. Med. China |
|
【ISSN】 |
1673-7342 |
|
【EISSN】 |
1673-7458 |
|
【DOI】 |
10.1007/s11684-008-0033-y |
|
【出版社】 |
Higher Education Press and Springer-Verlag |
|
【出版年】 |
2008 |
|
【卷期】 |
2
卷2期 |
|
【页码】 |
178-181
页,共
4
页 |
|
【作者】 |
TANG Zhongzhi;
LI Junyao;
YANG Jianhong;
|
|
【关键词】 |
endothelial cells; nitric oxide synthase type III; hypertension; serum lipid; blood glucose |
【摘要】 |
|
To study the relationship of the polymorphism of endothelial nitric oxide synthase (eNOS) gene and blood pressure, lipid profiles and blood glucose level. By using PCR-RFLP, the eNOS Glu298Asp gene polymorphism was detected in 184 patients with essential hypertension and 196 matched healthy individuals with normal blood pressure. Taking into account eNOS Glu298Asp polymorphisms, the relationship of blood pressure with triglycerides (TG), total cholesterol (TC), high density lipoprotein (HDL), low density lipoprotein (LDL) and blood glucose level was analyzed. The distribution of eNOS Glu298Asp polymorphism had no significant difference between different blood pressure groups and gender groups, but there was a significant difference between different age groups, diastolic blood pressure groups or BMI groups (P < 0.05). Asp/Asp genotype significantly increased the risk of hypertension in individuals with serum TC above 5.4 mmol/L (P = 0.03, OR = 2.65). eNOS Glu298Asp polymorphism and serum lipid could synergistically modulate the blood pressure. eNOS Asp/Asp genotype could significantly increase the risk of hypertension in individuals with serum TC over 5.4 mmol/L. eNOS Glu298Asp in combination with serum TC could be used to predict the risk of hypertension. |
|
